Joakim Soderberg

Turning strategy into reality in healthcare — focusing on how to get things done, not just what to do.

📍 Sweden🔄 Updated September 2026💼 6 investments📅 9 years investing🗓 Last invested May 2026
VC🌍 SwedenInvested this year
6
Total investments
4
Early stage
0
Mid stage
1
Late stage
9y
Years active

Portfolio

5 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
May 2026
Mediqor AB (Sweden) is a digital health platform company focused on Arabic-speaking populations in MENA and globally. We develop scalable, mobile-first health products that help users navigate care journeys, access trusted information, and connect to relevant providers and services. Flagship product: Mediqor Health App (launch planned for July 2026). What we deliver: - Consumer-grade UX built for trust and retention - Medical-quality content and structured health flows - AI-supported guidance and personalization (where compliant) - Partnership-ready platform for providers and organizations We welcome partnerships with clinics, provider networks, employers, insurers, and strategic investors.
Board Member
Mar 2024
Medtech4Health is a national Strategic Innovation Programme within medical technology. We work to implement more medical technological ideas and solutions in healthcare, and to create value for patients. To make this possible, we bring together stake holders in healthcare, academia and business in regional nodes and in different types of projects. Our aim is, through innovation, to streamline healthcare and strengthen the medical technology industry, nationally and internationally.
late stageMedical Device
Angel Investor
Nov 2022
Angel investor network formed by seasoned entrepreneurs investing smart money.
Angel Investor
Nov 2021
LSI Beta - en ny satsning för investeringar i start-upbolag inom life science Med de otroligt roliga erfarenheterna från LSI Alfa som snart har investerat hela sitt tillgängliga kapital i sju olika bolag startar vi LSI Beta. Vi har nu tagit in 10 miljoner SEK från ett 30-tal erfarna affärsänglar, som skall investeras i ca. 7 nya och spännande bolag under 2022.
Angel Investor
Dec 2020
LSI Alpha består av 20 delägare med bred erfarenhet inom entreprenörskap, tech och life science. Vi investerar i start-ups inom life science (seed) med såväl kapital som kompetens. LSI Alpha har en investeringskommitte bestående av 14 personer som strukturerat utvärderar potentiella bolag. Läs mer om vilka bolag vi söker här https://www.lifescienceinvest.se/lsi-alpha/
Experience · 11 entries
All (11)
Investments (6)
Founder (2)
Board (3)
2026
Board Member
May 2026
Mediqor AB (Sweden) is a digital health platform company focused on Arabic-speaking populations in MENA and globally. We develop scalable, mobile-first health products that help users navigate care journeys, access trusted information, and connect to relevant providers and services. Flagship product: Mediqor Health App (launch planned for July 2026). What we deliver: - Consumer-grade UX built for trust and retention - Medical-quality content and structured health flows - AI-supported guidance and personalization (where compliant) - Partnership-ready platform for providers and organizations We welcome partnerships with clinics, provider networks, employers, insurers, and strategic investors.
2024
Evaluator for Vinnova Calls
Mar 2024
Vinnova is Sweden’s innovation agency. Our mission is to promote sustainable growth by improving the conditions for innovation, as well as funding needs-driven research. Vinnova’s vision is for Sweden to be a world-leading country in research and innovation, an attractive place in which to invest and conduct business. We promote collaborations between companies, universities, research institutes and the public sector. We do this by stimulating a greater use of research, by making long-term investment in strong research and innovation milieus and by developing catalytic meeting places. Vinnova’s activities also focus on strengthening international cooperation. In order to increase our impact, we are also dedicated to interacting with other research financiers and innovation-promoting organisations. Every year Vinnova invests about SEK 2 billion in various initiatives. Vinnova is a Swedish government agency working under the Ministry of Enterprise, Energy and Communications and acts as the national contact agency for the EU Framework Programme for R&D. We are also the Swedish government’s expert agency within the field of innovation policy. Vinnova was founded in January 2001. About 200 people work here and we have offices in Stockholm and Brussels. Our Director General is Charlotte Brogren.
Board Member
Mar 2024
Medtech4Health is a national Strategic Innovation Programme within medical technology. We work to implement more medical technological ideas and solutions in healthcare, and to create value for patients. To make this possible, we bring together stake holders in healthcare, academia and business in regional nodes and in different types of projects. Our aim is, through innovation, to streamline healthcare and strengthen the medical technology industry, nationally and internationally.
late stageMedical Device
2022
Angel Investor
Nov 2022
Angel investor network formed by seasoned entrepreneurs investing smart money.
Head Of Business Development / Founder
Apr 2022
BCB Medical is the Nordic market leader in gathering and analysing clinical data. Our aim is to ensure that current and future generations live healthier lives. BCB Medical and Health Solutions joined forces in May 2021, and today we can offer even more services and new opportunities for our customers and partners to utilize the collected data. Together, we can build a bridge between Healthcare and Life Science, to realize the value that is today hidden in health data. We gather real-world data for medical effectiveness and treatment quality through an integrated proprietary platform. We combine, analyse and illustrate clinical data from various sources and present it in an understandable format. We revolutionize the way clinical data impacts people’s lives. We offer solutions for monitoring and analysing different disease groups. With our help, healthcare professionals around the world can provide better care for their patients and develop new forms of treatment. Our disease-specific treatment monitoring platforms are the de facto solution in Finnish healthcare, both in public and private sector. They are in active, daily use, and currently monitor and analyze more than 100 diseases groups.
Show all 11 entries ↓
Investment activity
2017–2026 · 6 investments
201712020120211202212024120261
Recent (last 2 years)Earlier